Heart disease is the leading cause of death for Americans. Kaiser Permanente Washington Health Research Institute (KPWHRI) scientists are working to understand how to reduce our risk of heart attacks, stroke, and other cardiovascular diseases throughout life.
Addressing risk factors, improving diagnosis, and exploring how medications, genes, and everyday life affect our cardiovascular health at different ages and stages are central to this work — as is translating research findings into practical, personalized care.
“We’ve found that helping patients and health care teams work together on personalized care plans is the best path to lifelong heart health,” says Beverly Green, MD, MPH, whose recent work has focused on improving the diagnosis of high blood pressure.
Additional focus areas for KPWHRI scientists include exploring the impact of cardiovascular diseases on other health conditions — and vice versa. Recently, this has led researchers Sascha Dublin, MD, PhD, and Laura B. Harrington, PhD, MPH, to investigate the impact of COVID-19 on cardiovascular health.
Below are other research highlights from KPWHRI’s cardiovascular health scientists (please visit their bios to learn more):
LaCroix AZ, Lang J, Scherr P et al. Cigarette smoking and five-year cardiovascular mortality in older men and women. Circulation. 1990;82(Supplement III):258. PubMed
Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure. Am J Cardiol. 1990;66(16):12G-14G. PubMed
O'Connor PJ, Wagner EH, Strogatz DS. Hypertension control in a rural community. An assessment of community-oriented primary care. J Fam Pract. 1990;30(4):420-4. PubMed
Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990;263(12):1653-7. PubMed
Forstrom M, Reid LD, Stergachis A, Corliss D. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic. Drug Intell Clin Pharm. 1990;24(3):304-9. PubMed
![]() Sascha Dublin, MD, PhDSenior Investigator |
![]() Beverly B. Green, MD, MPHSenior Investigator |
![]() Laura Harrington, PhD, MPHAssociate Investigator |
![]() Ellen O'Meara, PhDPrincipal Collaborative Scientist |
![]() Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
![]() Meagan C. Brown, PhD, MPHAssistant Investigator |
James Floyd, MD, MS
Assistant Professor, Department of Medicine
Adjunct Assistant Professor, Department of Epidemiology
University of Washington
Susan Heckbert, MD, PhD
University of Washington (UW) Department of Epidemiology; UW Cardiovascular Health Research Unit
Nicholas L. Smith, PhD, MPH
UW Professor, Epidemiology, Cardiovascular Health Research Unit
Director, Seattle Epidemiology and Information Resource Center, VA Puget Sound Health Care System